In the wake of the FDA Modernization Act and translational rates of cancer drugs into the clinic at just 20%, it is critical that oncology scientists invest in more...

Through many years of neglect, the field of women's health has long been under researched and underfunded, resulting in the misdiagnosis and mistreatment of females across the...

Whilst PROTACs continue to make headwind, much of the heterobifunctional and monovalent opportunity beyond the ubiquitin proteosome system remains untapped, drawing in new and...